1 year return (CAGR)
76.91%
Monte Rosa Therapeutics Inc Exchange (NASDAQ, USD)
GLUE
12.26
+0.13 (+1.07%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
26.68%
5 year return (CAGR)
-17.58%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.05B
Price/Sales
36.41
Ent value
1.17B
Price/Book
2.16
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-32.09%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 12.20 |
| Daily high | 12.31 |
| Daily low | 12.06 |
| Daily Volume | 1.13M |
| All-time high | 42.21 |
| 1y analyst estimate | 28.50 |
| Beta | 1.53 |
| EPS (TTM) | -1.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| GLUE | S&P500 | |
| Current price drop from All-time high | -70.95% | -0.56% |
| Highest price drop | -94.08% | -56.47% |
| Date of highest drop | 26 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -73.54% | -10.68% |
| Avg time to new high | 60 days | 12 days |
| Max time to new high | 1266 days | 1805 days |
News
